Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Directorate Change

16 Nov 2005 07:02

Marchpole Holdings PLC16 November 2005 For Immediate Release 16 November 2005 Marchpole Holdings PLC ("Marchpole") Appointment of Non-Executive Directors Marchpole Holdings plc, which designs, produces and sells high quality clothingand accessories for six world class brands, is pleased to announce theappointment of Ronnie Stirling and Harvey Shulman who will be joining the Boardwith immediate effect as non-executive Directors. Greg Tufnell, CEO of Marchpole said: "We are delighted to welcome both Ronnieand Harvey to the Board. Their combined experience is very relevant to ourbusiness - encompassing both fashion and corporate worlds and will be extremelyuseful as Marchpole continues to grow into a world-leading brand manager." Ronald Edward Stirling (aged 65) joins Marchpole with a wealth of experiencewithin the fashion industry having founded the Stirling Cooper Fashion Group in1968. Stirling Cooper traded as a manufacturer, wholesaler and retail fashionclothing company with 11 retail outlets and 20 in-store concessions. Since hisretirement in 1991, he has concentrated on his family's private investmentcompany which has made a number of investments in early stage companies. From February 1995 until October 2002, Ronnie was the President of Kasper ASLEurope Limited a subsidiary of a large USA Fashion Company selling the productsof Anne Klein, Albert Nippon and Kasper ASL and opened in-store shops withinmajor stores in the UK and Europe. He then became a consultant of Kasper ASLfrom October 2002 until October 2003 Current directorships include:Fastnet investments Limited, American Collections (Europe) Limited,Azure Holdings Plc and;The Niche Group Plc. Previous directorships included:Abbcott Properties Limited,Devere Publishing Group Limited and; Other disclosures Ronnie Stirling was a Director of Hay & Robertson in October 2003 which was putinto liquidation in February 2004 and a Director of Knights International in Nov1992 which was put into liquidation in November 1993. He was also a director ofStirling Cooper Limited from 1968 to 1985 which was put into liquidation in1985. Harvey Barry Shulman, LL.B, LL.M, (aged 59) brings extensive corporate and legalexperience to the Board. Harvey trained as a solicitor and has been involved inproperty acquisition and management since 1988. He is currently joint managingdirector of Solitaire Group Plc where he has been since its flotation on AIM in1997. He is also a partner in Graham Harvey, solicitors, with which he has beenassociated since 1972. Harvey's current directorships include; Adrenaline Media plcErgotrade LimitedHerav Holdings LimitedHudson (Edgware) LimitedLink Assured Management LimitedMorbury LimitedOakmead Residents Company LimitedPriory court (Southend) Residents Company LimitedSolitaire Finance LimitedSolitaire Residential Holdings LimitedSolitaire Holdings LimitedSpeedpoint Finance LimitedCampus Marketing plcFreehold Managers plcHolding & Management (Solitaire) LimitedIncome Stream LimitedLink Furnishing plcMoss Kaye LimitedPembertons Residential LimitedString of Pearls 2 plcSolitaire Group plcSolitaire Properties LimitedSolitaire Secretaries LimitedSouthern & District Finance LimitedDebmill LimitedGenoa Quay No.1 Residents Company LimitedHolding & Management (Solitaire) no.2 LimitedLifestyle Solution LimitedMontrose House Management LimitedNews on the Block plcPhillips & Associates LimitedQueensway Developments LimitedSolitaire Property Management Company LimitedSolitaire Residential LimitedProperty Investment Portfolio Services LimitedSolitaire Asset Management LimitedTrading New Home Plc Past Directorships (the majority of which have not traded)Marina Park Residents Association LimitedCastle Marina Residents Association LimitedMoss Kaye Pembertons LimitedGround Rent Acquisitions VI LimitedPaisley Pattern Homes LimitedReversionary Gains IV LimitedUnchained Growth VIII LimitedGround Renters VI LimitedUnchained Growth V LimitedUncapped Growth plcGround Renters III plcReversionary Gains I (First Nominees) LimitedReversionary Gains II Second Nominees) LimitedUnchained Growth IV plcUnchained Growth Pubs III plcUnchained Growth Pubs VI plcGround Rent Acquisitions IV LimitedReversionary Gains I LimitedReversionary Gains II LimitedRiverside Court Management (BSE) LimitedUnchained Reversions LimitedUnchained Growth VII LimitedParagon Protected Growth plcGlobal Income LimitedGround Renters I LimitedGround Renters IV LimitedReversionary Gains II (First Nominees) LimitedReversionary Gains III (First Nominees) LimitedUnchained Growth II plcUnchained Growth Pubs I plcUnchained Growth Pubs IV plcGround Rent Acquisitions V LimitedReversionary Gains III LimitedSouth Eastern Close Nominees LimitedOne Good Move LimitedUnchained Growth VI LimitedTallwell LimitedGround Renters II plcGround Renters V LimitedLink Capital LimitedReversionary Gains II (Third Nominees) LimitedReversionary Gains Management LimitedSecondary Gains LimitedUnchained Growth III plcUnchained Growth Pubs II plcUnchained Growth Pubs V plcGround Rent Acquisitions I LimitedBES Films Limited Other disclosures H.B. Shulman has been a director of a number of companies over the last fiveyears which have not traded and have not been included in the list above. These directorships have been omitted on the grounds that this information is ofminor importance only and is not likely to influence the assessment of theCompany's assets and liabilities, financial position, profits and losses andprospects. These directorships were of companies which were formed as part ofthe proposed acquisition by Solitaire of a substantial apartment block inpreparation for the acquisition of separate units in the block. The proposedacquisition aborted and these companies became redundant and have never traded. Receiverships, liquidation, administrations of companies or partnerships orreceiverships of assetsH. B. Shulman was a non-executive director of Unchained Growth Pubs I plc from20 July 1994, Unchained Growth Pubs II plc and Unchained Growth Pubs III plcfrom 21 February 1996, Unchained Growth Pubs IV plc from 30 January 1996,Unchained Growth Pubs V plc and Unchained Growth Pubs VI plc. from 24 January1997, all until 3 June 2003. On 18 June 2003 an administrative receiver of eachof these companies were appointed by HSBC Bank plc. Immediately after theappointment of the administrative receiver, the business and assets of thecompanies have been sold. H.B. Shulman together with his co non-executivedirector objected to the appointment of the administrative receiver on thegrounds that it was not necessary. They were overruled and as a result they bothresigned as directors. There are no other disclosures required under the Listing Rules. For further information please contact: Marchpole: 020 7908 7777Greg Tufnell Chief Executive Shore Capital 020 7408 4090Alex BorrelliBuchanan Communications: 020 7466 5000Tim Thompson / Nicola Cronk Notes to editors Marchpole is brand manager for six high quality labels: Emanuel Ungaro; Ungaro;Yves Saint Laurent; Boateng; Jean-Charles de Castelbajac ('JCC') andJean-Charles de Castelbajac / Rossignol. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Feb 20197:00 amRNSBoard Change
25th Jan 201911:10 amRNSPublication of F-4
18th Jan 20197:00 amRNSNew Deferred Bonus Plan
15th Jan 20197:00 amRNSBGS-649 Phase 2b data to be Presented at ENDO 2019
27th Dec 201810:02 amRNSDirector/PDMR Shareholding
24th Dec 20187:00 amRNSDirector/PDMR Shareholding
18th Dec 20187:00 amRNSPositive results from safety extension study
17th Dec 20186:25 pmRNSPositive results from safety extension study
17th Dec 20183:44 pmRNSAIM Rule 17 Disclosure Statement
10th Dec 20187:00 amRNSPresentation at BMO Healthcare Conference
5th Dec 20181:09 pmRNSProposed combination of Mereo and OncoMed
26th Nov 20187:00 amRNSIssue of Warrants
5th Nov 20187:00 amRNSFirst patient dosed in Phase 2 study
31st Oct 20183:37 pmRNSTotal Voting Rights
15th Oct 20187:00 amRNSCompletion of Patient Enrolment in Phase 2b study
1st Oct 201810:00 amRNSRevised Credit Facility and Issue of Warrants
3rd Sep 20187:00 amRNSBlock Listing Application
31st Aug 20186:25 pmRNSCorrection to Issued Share Capital
8th Aug 20187:00 amRNSMereo BioPharma Interim Results 2018
23rd Jul 20187:00 amRNSExercise of Options
23rd Jul 20187:00 amRNSNotice of Interim Results
21st Jun 201812:52 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSSuccessful Completion of PrimaryBid Offer
25th May 20184:31 pmRNSPrimaryBid.com Offer
22nd May 20187:00 amRNSNotice of AGM
27th Apr 20187:00 amRNSGrant of Options
26th Apr 20187:00 amRNSUpdate on Offering & Application to List on Nasdaq
9th Apr 201811:34 amRNSOffering and Application to List on Nasdaq
6th Apr 20181:03 pmRNSResult of General Meeting
3rd Apr 20187:00 amRNSPublication of Annual Report
26th Mar 20187:00 amRNSMereo BioPharma Files for Proposed Global Offering
23rd Mar 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSPUBLICATION OF NOTICE OF GENERAL MEETING
20th Mar 20187:00 amRNSMereo selected for oral presentation at ATS 2018
19th Mar 20187:00 amRNSMereo: Positive Top-Line Results for BGS-649
26th Feb 20187:00 amRNSMereo BioPharma Appoints Wills Hughes-Wilson
2nd Jan 20187:00 amRNS£10m credit facility drawdown & issue of warrants
18th Dec 20177:00 amRNSMereo Plans to Conduct Registered IPO in the US
13th Dec 20177:00 amRNSMereo BioPharma: Business Update
11th Dec 20177:00 amRNSPositive results from Phase 2 trial with BCT-197
13th Nov 20177:00 amRNSBPS-804 receives PRIME designation
6th Nov 201712:19 pmRNSHolding(s) in Company
30th Oct 20177:00 amRNSMereo announces agreement with AstraZeneca
18th Sep 20177:00 amRNSMereo to Present at Cantor Healthcare Conference
5th Sep 20177:00 amRNSUpdate on BGS-649 Phase 2b Study
22nd Aug 20179:17 amRNSIssue of Warrants
8th Aug 20177:12 amRNSInterim Results
3rd Jul 20177:00 amRNSNotice of Results
27th Jun 201711:23 amRNSResult of AGM
15th May 20177:00 amRNSUpdate on acumapimod Phase 2 Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.